Levreg Partners and Kyowa Kirin are accelerating patient identification, retention, and HCP engagement for Poteligeo® with a custom LLM engine built in under three months. The field-ready tool integrates with existing systems, delivers voice- and text-driven insights, and pinpoints ideal patients and prescribers in real time. Early results project 10–15% revenue growth, 3–4x ROI, faster time to prescribe, and meaningful value for HCPs and patients across rare cutaneous lympho